Technologies give high-resolution 'snapshot' of cancer tissues

November 21, 2011 By Christopher Vaughan in Cancer

(Medical Xpress) -- Stanford researchers have melded tools and technologies from engineering, computer science and stem cell biology to analyze hundreds of individual cancer cells and draw the most accurate portrait yet of the cellular composition of human colon cancer tissues.

In doing so, they have shown that the development of cancer is a kind of caricature of normal , and have discovered markers that allow them to gauge more accurately how dangerous a cancer is likely to be. They hope the work will lead to better and more targeted cancer therapies.

In tumor tissues, not all are created equal. Solid tumors usually contain many kinds of cancer cells, each of which might be more or less dangerous, and may vary in how they respond to various anti-cancer therapies. One major problem researchers have had in understanding cancer is that when they analyze a cancerous lesion, they usually look at whole-tumor samples that contain a mixture of all these cells types. Amidst this diversity, spotting the signs that betray the really dangerous cells is difficult, like trying to draw the psychological profile of a murderer by sending out questionnaires to everyone who ever committed a legal infraction.

In a paper published online Nov. 13 in , a team led by Stephen Quake, PhD, and Michael Clarke, MD describes how they used the single-cell PCR microfluidic technology invented in the Quake laboratory to analyze the individual gene-expression profile of hundreds of single , which then they grouped into different subtypes.

“We have spent the last several years developing single-cell genomic measurement technologies,” said Quake, the Lee Otterson Professor in the School of Engineering and a professor of bioengineering and of applied physics. “To finally get all the tools together and produce a biologically important result is very gratifying.”

Using these technologies to analyze the gene-expression patterns of single cells, one by one, allows the researchers to dissect their different identities and clarify the physiology of complex tissue systems, explained Piero Dalerba, MD, instructor of medicine and co-first author of the study. The two other first authors are research associate Tomer Kalisky, PhD, and Debashis Sahoo, PhD, instructor of pathology. Taking advantage of a computer search technique newly developed by Sahoo, the authors identified 47 differentially expressed genes that are useful for the visualization of the various kinds of cells in the tumor.

“In a single experiment, we can now take a ‘snapshot’ of the cell composition of a specific tissue, visualize its different cellular subsets and easily discover novel markers to define them,” said Kalisky.

This methodology is important for the study of minority populations of cells, such as stem and progenitor cells, said Clarke, professor of oncology and the Karel H. and Avice N. Beekhuis Professor in Cancer Biology. “Using these techniques, we have cut a decade off the attempt to understand cellular hierarchy in tissues.”

The investigators noted that the study resulted from the close working relationships between researchers in various departments. “This project is the product of a fantastic synergy between engineers, computer scientists, stem cell biologists and medical oncologists, made possible by the interdisciplinary environment we have here at Stanford,” said Sahoo.

One of the key results of the work is that it revealed why there are many kinds of cancer cells in a tumor. One theory has been that cancer cells have an unstable genome and change in random ways as they reproduce. This research showed that cells change along the same developmental lines followed by normal colon cells during differentiation processes. Like a caricature portrait, which is recognizably someone’s face even though certain features are exaggerated, the underlying order in cancer cell development is recognizably the same as in normal cells, although the percentage of individual cell types is abnormally expanded or reduced.

“What we see is that the cellular heterogeneity of colon-tumor tissues mirrors and recapitulates the lineage diversity of the normal colon epithelium, including both immature progenitor-like cells and more mature, specialized cells,” said Dalerba.

The researchers also showed that all the types of cancer cells in a colon tumor could spring from the differentiation of a single cancer cell, a process reminiscent of a stem-cell system.

One aspect of the research with potential clinical applications was the finding that tumors with a gene-expression profile similar to that of more immature cell types were more dangerous than those whose profile resembled more differentiated, specialized cells. The researchers developed a two-gene classification system that could be used to accurately predict how lethal a colon tumor was likely to be. They also showed that this simple, two-gene system predicted clinical outcomes more accurately than pathological grading of tumor samples, which is one of the few important parameters used by pathologists to define a tumor’s aggressiveness.

The researchers hope that use of this technology will lead to therapies that can target the most dangerous cells in a tumor.

Provided by Stanford University Medical Center search and more info website

5 /5 (2 votes)  

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

nanotech_republika_pl
Nov 21, 2011

Rank: not rated yet
This sounds awesome! Except that we keep hearing about breakthroughs in cancer study all the time. When will we break through for sure?
Rank 5 /5 (2 votes)
Relevant PhysicsForums posts

More news stories

ASCO: combo antibody therapy effective for melanoma

(HealthDay)—Concurrent use of two immune checkpoint antibodies—ipilimumab and nivolumab—may be effective for the treatment of advanced melanoma, according to a proof-of-principal study presented in ...

Cancer created 10 hours ago | popularity not rated yet | comments 0

Risk factors ID'd for poor cutaneous cell CA outcomes

(HealthDay)—The risks of metastasis and death associated with cutaneous squamous cell carcinoma (CSCC) are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond ...

Cancer created 11 hours ago | popularity not rated yet | comments 0 | with audio podcast

Physical & emotional impairments common, often untreated in people with cancer

A new review finds cancer survivors suffer a diverse and complex set of impairments, affecting virtually every organ system. Writing in CA: A Cancer Journal for Clinicians, Julie Silver, M.D., associate professor at Harvar ...

Cancer created 15 hours ago | popularity not rated yet | comments 0

Calif. doc with 'cancer cure' gets 14 years prison (Update)

(AP)—A California doctor has been sentenced to 14 years in federal prison for bilking her patients out of more than $1 million by promising that an herbal supplement could cure late-stage cancer and other diseases.

Cancer created 16 hours ago | popularity not rated yet | comments 0

New protein-targeting drug shows promise in early trial for patients with high-risk CLL

A new oral targeted drug, idelalisib (GS-1101), has the potential to stave off the need for additional treatments for relapsed or treatment-resistant chronic lymphocytic leukemia (CLL), according to a study led in part by ...

Cancer created 17 hours ago | popularity not rated yet | comments 0 | with audio podcast


For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests

Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...

Flesh-eating disease victim gets prosthetic hands

(AP)—A woman who lost both hands, her left leg and right foot after contracting a flesh-eating disease has been fitted with prosthetic hands.

Temporal processing in the olfactory system

The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...

Melon focus headband turns to Kickstarter for rollout plans

(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...

Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria

In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...

College women exceed NIAAA drinking guidelines more frequently than college men

In order to avoid harms associated with alcohol consumption, in 2009 the National Institute on Alcohol Abuse and Alcoholism issued guidelines that define low-risk drinking. These guidelines differ for men and women: no more ...